Friday, October 7

Tag: life sciences

GE’s Healthcare Business to Be Spun Out First Week of January
Business

GE’s Healthcare Business to Be Spun Out First Week of January

Text size A new day is coming for GE's healthcare business. It will be a standalone company in early 2023. Loic Venance/AFP via Getty Images General Electric is spinning off its healthcare business in early January. With that just around the corner, GE named the board of directors for the business. GE (ticker: GE) CEO Larry Culp will serve as the non-executive cha...
What do retail and pharmacy have in common? How RFID technology can serve as part of a comprehensive solution to diversion
Science

What do retail and pharmacy have in common? How RFID technology can serve as part of a comprehensive solution to diversion

Retail and pharmacy – two very different industries that, on the surface, might not appear to have much in common. However, the two fields have found a use for an emerging technology to solve very similar problems. Radio frequency identification (RFID) technology is an incredibly valuable resource that has been introduced in the retail space to track inventory and detect and deter theft. Now, RFID is bringing immense value to the healthcare space,continuing to show promise and results, especially when incorporated into a comprehensive drug diversion prevention program. RFID technology uses wireless communication and radio waves to identify and track items and equipment. RFID tags can store a significant amount of data, whether it be a single serial number or several pages of material. Wi...
The new paradigm in drug development: Why platform technology is the solution patients and payers need
Science

The new paradigm in drug development: Why platform technology is the solution patients and payers need

We are living in a dynamic time of drug development and innovation with many beneficiaries—the most important being the patient. These developments include everything from exciting gene therapies for rare diseases to mRNA technology that allowed the development of the COVID vaccine in record time. Yet we are facing significant challenges as well. There is a global call for more equitable pricing and broader access—especially for the newer innovative treatments. How can we as healthcare leaders answer that call? How can we work with our stakeholders to ensure that the system can effectively support new innovations so that the most important stakeholder—the patient—will benefit? Collaboration and partnerships In answering the call, we must focus our attention on where it has the most impa...